1. Home
  2. NEO vs IMKTA Comparison

NEO vs IMKTA Comparison

Compare NEO & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • IMKTA
  • Stock Information
  • Founded
  • NEO 2001
  • IMKTA 1963
  • Country
  • NEO United States
  • IMKTA United States
  • Employees
  • NEO N/A
  • IMKTA N/A
  • Industry
  • NEO Precision Instruments
  • IMKTA Food Chains
  • Sector
  • NEO Health Care
  • IMKTA Consumer Staples
  • Exchange
  • NEO Nasdaq
  • IMKTA Nasdaq
  • Market Cap
  • NEO 1.2B
  • IMKTA 1.2B
  • IPO Year
  • NEO 1999
  • IMKTA N/A
  • Fundamental
  • Price
  • NEO $8.04
  • IMKTA $60.76
  • Analyst Decision
  • NEO Buy
  • IMKTA
  • Analyst Count
  • NEO 9
  • IMKTA 0
  • Target Price
  • NEO $13.31
  • IMKTA N/A
  • AVG Volume (30 Days)
  • NEO 3.1M
  • IMKTA 123.4K
  • Earning Date
  • NEO 04-29-2025
  • IMKTA 05-08-2025
  • Dividend Yield
  • NEO N/A
  • IMKTA 1.09%
  • EPS Growth
  • NEO N/A
  • IMKTA N/A
  • EPS
  • NEO N/A
  • IMKTA 3.26
  • Revenue
  • NEO $672,361,000.00
  • IMKTA $5,410,455,434.00
  • Revenue This Year
  • NEO $13.05
  • IMKTA N/A
  • Revenue Next Year
  • NEO $11.18
  • IMKTA N/A
  • P/E Ratio
  • NEO N/A
  • IMKTA $18.72
  • Revenue Growth
  • NEO 10.10
  • IMKTA N/A
  • 52 Week Low
  • NEO $6.08
  • IMKTA $58.92
  • 52 Week High
  • NEO $19.11
  • IMKTA $82.01
  • Technical
  • Relative Strength Index (RSI)
  • NEO 43.86
  • IMKTA 43.40
  • Support Level
  • NEO $7.66
  • IMKTA $59.41
  • Resistance Level
  • NEO $8.31
  • IMKTA $63.74
  • Average True Range (ATR)
  • NEO 0.76
  • IMKTA 1.53
  • MACD
  • NEO -0.01
  • IMKTA -0.14
  • Stochastic Oscillator
  • NEO 45.94
  • IMKTA 26.73

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

Share on Social Networks: